← back to search

Paul H. Levine

University of Illinois Chicago · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research focused on Confidence interval and Hazard ratio, with related work in Cancer, Ulcerative colitis, Cancer research. Notable publications include 'Impact of Patient Navigation on Timely Cancer Care: The Patient Navigation Research Program', 'Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program', and 'Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy'.
h-index
—
citations
423
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

OP06 Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study
Journal of Crohn s and Colitis 2024cited by 16position: middledoi
Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program
Cancer 2016cited by 56position: middledoi
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Clinical Breast Cancer 2015cited by 56position: middledoi
Impact of Patient Navigation on Timely Cancer Care: The Patient Navigation Research Program
JNCI Journal of the National Cancer Institute 2014cited by 295position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Electra D. Paskett · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute2 papers (2014–2016)Karen M. Freund · Tufts University2 papers (2014–2016)Frederick R. Snyder · University of Illinois Chicago2 papers (2014–2016)Donald J. Dudley · Norwegian Womens Public Health Association2 papers (2014–2016)Ji‐Hyun Lee · ETH Zurich2 papers (2014–2016)Peter C. Raich · Denver Health Medical Center2 papers (2014–2016)Ezequiel Neimark · Nutrition-Génétique et Exposition aux Risques Environnementaux1 papers (2024–2024)Judith D. Goldberg · NYU Langone Health1 papers (2015–2015)Remo Panaccione · Nutrition-Génétique et Exposition aux Risques Environnementaux1 papers (2024–2024)Kori Wallace · Nutrition-Génétique et Exposition aux Risques Environnementaux1 papers (2024–2024)Sherleen Chen · AbbVie (United States)1 papers (2024–2024)Shah Giashuddin · NewYork–Presbyterian Brooklyn Methodist Hospital1 papers (2015–2015)Rezina Arju · New York University1 papers (2015–2015)Silvia C. Formenti · NYU Langone’s Laura and Isaac Perlmutter Cancer Center1 papers (2015–2015)Tsivia Hochman · New York University1 papers (2015–2015)W. Rachel Duan · AbbVie (United States)1 papers (2024–2024)Elizabeth M. Whitley · The University of Texas MD Anderson Cancer Center1 papers (2014–2014)Eleonora Teplinsky · New York University1 papers (2015–2015)Kevin Fiscella · University of Rochester Medical Center1 papers (2014–2014)Marc Ferrante · Universitair Ziekenhuis Leuven1 papers (2024–2024)